Jerzy K.
- Country
- Poland
- Department
- Klinika Hematologii, Onkologii i Transplantologii Dziecięcej
Research Overview
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Evaluation of Ruxolitinib Combined with AIEOP-BFM 2017 Chemotherapy in Pediatric Acute Lymphoblastic Leukemia with JAK/STAT Pathway Activation
- Phase III Randomized Study of Bortezomib and Blinatumomab with Methotrexate in Pediatric Acute Lymphoblastic Leukemia
Data & Insights
Has run more than one trial at 15 of 165 partner sites.
Specializations
Pediatric Hematologic Oncology
This clinical investigator specializes in treating acute lymphoblastic leukemia (ALL) in children and adolescents, with particular emphasis on high-risk patient populations.
- Philadelphia chromosome-positive ALL
- Standard and high-risk ALL variants
- JAK/STAT pathway activation in ALL
The investigator's work encompasses innovative therapeutic approaches in pediatric leukemia treatment protocols.
Targeted Therapy Expertise
The investigator focuses on implementing targeted therapeutic agents in pediatric leukemia treatment, including molecular pathway inhibitors and immunotherapy approaches.
- Tyrosine kinase inhibitor therapy
- Proteasome inhibition strategies
- JAK/STAT pathway targeting
Their work integrates novel targeted agents with established chemotherapy protocols.
Treatment Response Assessment
The investigator specializes in evaluating and monitoring treatment response in pediatric leukemia patients using advanced diagnostic methods.
- Minimal Residual Disease monitoring
- Risk-adapted therapy approaches
- Disease-free survival assessment
Their expertise includes implementing response-based treatment modifications and long-term outcome evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.